THE CHEMOTHERAPY FOUNDATION INC (EIN 132622978) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1968

Legal Domicile

Principal Officer

MICHAEL G ROSENBERG

Phone

2122139292

Tax Period

2023-01-01 to 2023-12-31

THE CHEMOTHERAPY FOUNDATION INC, founded in 1968, is a micro nonprofit that reported $80K in total revenue in fiscal year 2023. Revenue fell 55% from the prior year — a significant decline worth monitoring. Expenses of $375K exceeded revenue, resulting in a 371% operating deficit.

Mission

OUR MISSION IS TO STIMULATE THE DISCOVERY AND DEVELOPMENT OF INNOVATIVE THERAPIES FOR THE CONTROL, CURE, AND PREVENTION OF CANCER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $233,775

Program Service Revenue $605

Investment Income $-35,617

Other Revenue $-119,184

TOTAL REVENUE $79,579

Expense Breakdown

Grants Paid $81,000

Salaries & Benefits $139,185

Fundraising Expenses $83,909

Program Expenses $231,667

Other Expenses $154,561

TOTAL EXPENSES $374,746

Year-over-Year Comparison

	2023	2022	Change
Revenue	$79,579	$178,027	-0.6%
Expenses	$374,746	$463,847	-0.2%
Net Income	$-295,167	$-285,820	+0.0%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$120,000

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MICHAEL G ROSENBERG	CHAIR OF THE BOARD	2.00	Officer Director	$0	$0	$0
CRAIG J GOLDBERG	TREASURER/SECRETARY	2.00	Director	$0	$0	$0
PETER ALKALAY	TRUSTEE	1.00	Director	$0	$0	$0
SUZANNE M MILLER PHD	TRUSTEE	2.00	Director	$0	$0	$0
WILLIAM K OH	TRUSTEE	2.00	Director	$0	$0	$0
ERIC S RICHTER	TRUSTEE	2.00	Director	$0	$0	$0
TALIA BIRAN	TRUSTEE	2.00	Director	$0	$0	$0
PAOLA G MUGGIA	EXECUTIVE DIRECTOR	50.00	Officer	$120,000	$0	$120,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	No data	No data	No data	No data
2023	$79,579	$374,746	$317,311	$-295,167
2022	$178,027	$463,847	$509,696	$-285,820
2021	$563,954	$627,801	$857,401	$-63,847
2020	$167,301	$430,444	$915,123	$-263,143
2019	$330,202	$1,019,751	$1,305,022	$-689,549
2018	$470,966	$1,108,269	$1,910,388	$-637,303

THE CHEMOTHERAPY FOUNDATION INC